Nathan Jones's questions to DONALDSON Co (DCI) leadership • Q4 2025
Question
Nathan Jones from Stifel Financial Corp followed up on the bioprocessing business, asking what fundamental market changes are needed to drive growth. He also asked for details on the company's connected solutions, specifically the scale of the expected 30% increase in connected machines and the monetization strategy.
Answer
Chairman, CEO & President Tod Carpenter explained that for bioprocessing, the company must first complete new product development and scale up GMP manufacturing, with significant commercialization expected in fiscal 2027. Regarding connected solutions, he clarified it is not a subscription model but a strategy to deepen customer relationships, which has been proven to increase the pull-through of higher-margin replacement parts and services, helping shift the Industrial segment's sales mix to 50% aftermarket.